Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: Possible mechanism of cardioprotection

Keith D. Garlid, Petr Paucek, Vladimir Yarov-Yarovoy, Holt N. Murray, Raymond B. Darbenzio, Albert J. D'Alonzo, Nicholas J. Lodge, Mark A. Smith, Gary J. Grover

Research output: Contribution to journalArticle

914 Citations (Scopus)

Abstract

Previous studies showed a poor correlation between sarcolemmal K+ currents and cardioprotection for ATP-sensitive K+ channel (K(ATP)) openers. Diazoxide is a weak cardiac sarcolemmal K(ATP) opener, but it is a potent opener of mitochondrial K(ATP), making it a useful tool for determining the importance of this mitochondrial site. In reconstituted bovine heart K(ATP), diazoxide opened mitochondrial K(ATP) with a K( 1/4 ) of 0.8 μmol/L while being 1000-fold less potent at opening sarcolemmal K(ATP). To compare cardioprotective potency, diazoxide or cromakalim was given to isolated rat hearts subjected to 25 minutes of global ischemia and 30 minutes of reperfusion. Diazoxide and cromakalim increased the time to onset of contracture with a similar potency (EC25, 11.0 and 8.8 μmol/L, respectively) and improved postischemic functional recovery in a glibenclamide (glyburide)-reversible manner. In addition, sodium 5- hydroxydecanoic acid completely abolished the protective effect of diazoxide. Whole-myocyte studies showed that diazoxide was significantly less potent than cromakalim in increasing sarcolemmal K+ currents. Diazoxide shortened ischemic action potential duration significantly less than cromakalim at equicardioprotective concentrations. We also determined the effects of cromakalim and diazoxide on reconstituted rat mitochondrial cardiac K(ATP) activity. Cromakalim and diazoxide were both potent activators of K+ flux in this preparation (K( 1/4 ) values, 1.1±0.1 and 0.49±0.05 μmol/L, respectively). Both glibenclamide and sodium 5-hydroxydecanoic acid inhibited K+ flux through the diazoxide-opened mitochondrial K(ATP). The profile of activity of diazoxide (and perhaps K(ATP) openers in general) suggests that they protect ischemic hearts in a manner that is consistent with an interaction with mitochondrial K(ATP).

Original languageEnglish (US)
Pages (from-to)1072-1082
Number of pages11
JournalCirculation Research
Volume81
Issue number6
StatePublished - 1997
Externally publishedYes

Fingerprint

Diazoxide
Adenosine Triphosphate
Cromakalim
Glyburide
mitochondrial K(ATP) channel
Sodium
Contracture
Muscle Cells
Action Potentials
Reperfusion
Ischemia

Keywords

  • ATP-sensitive K channel
  • Heart
  • Mitochondria
  • Myocardial ischemia

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Garlid, K. D., Paucek, P., Yarov-Yarovoy, V., Murray, H. N., Darbenzio, R. B., D'Alonzo, A. J., ... Grover, G. J. (1997). Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: Possible mechanism of cardioprotection. Circulation Research, 81(6), 1072-1082.

Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels : Possible mechanism of cardioprotection. / Garlid, Keith D.; Paucek, Petr; Yarov-Yarovoy, Vladimir; Murray, Holt N.; Darbenzio, Raymond B.; D'Alonzo, Albert J.; Lodge, Nicholas J.; Smith, Mark A.; Grover, Gary J.

In: Circulation Research, Vol. 81, No. 6, 1997, p. 1072-1082.

Research output: Contribution to journalArticle

Garlid, KD, Paucek, P, Yarov-Yarovoy, V, Murray, HN, Darbenzio, RB, D'Alonzo, AJ, Lodge, NJ, Smith, MA & Grover, GJ 1997, 'Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: Possible mechanism of cardioprotection', Circulation Research, vol. 81, no. 6, pp. 1072-1082.
Garlid, Keith D. ; Paucek, Petr ; Yarov-Yarovoy, Vladimir ; Murray, Holt N. ; Darbenzio, Raymond B. ; D'Alonzo, Albert J. ; Lodge, Nicholas J. ; Smith, Mark A. ; Grover, Gary J. / Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels : Possible mechanism of cardioprotection. In: Circulation Research. 1997 ; Vol. 81, No. 6. pp. 1072-1082.
@article{6fe1f95d3d5b4869b33b81de518d7ea8,
title = "Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: Possible mechanism of cardioprotection",
abstract = "Previous studies showed a poor correlation between sarcolemmal K+ currents and cardioprotection for ATP-sensitive K+ channel (K(ATP)) openers. Diazoxide is a weak cardiac sarcolemmal K(ATP) opener, but it is a potent opener of mitochondrial K(ATP), making it a useful tool for determining the importance of this mitochondrial site. In reconstituted bovine heart K(ATP), diazoxide opened mitochondrial K(ATP) with a K( 1/4 ) of 0.8 μmol/L while being 1000-fold less potent at opening sarcolemmal K(ATP). To compare cardioprotective potency, diazoxide or cromakalim was given to isolated rat hearts subjected to 25 minutes of global ischemia and 30 minutes of reperfusion. Diazoxide and cromakalim increased the time to onset of contracture with a similar potency (EC25, 11.0 and 8.8 μmol/L, respectively) and improved postischemic functional recovery in a glibenclamide (glyburide)-reversible manner. In addition, sodium 5- hydroxydecanoic acid completely abolished the protective effect of diazoxide. Whole-myocyte studies showed that diazoxide was significantly less potent than cromakalim in increasing sarcolemmal K+ currents. Diazoxide shortened ischemic action potential duration significantly less than cromakalim at equicardioprotective concentrations. We also determined the effects of cromakalim and diazoxide on reconstituted rat mitochondrial cardiac K(ATP) activity. Cromakalim and diazoxide were both potent activators of K+ flux in this preparation (K( 1/4 ) values, 1.1±0.1 and 0.49±0.05 μmol/L, respectively). Both glibenclamide and sodium 5-hydroxydecanoic acid inhibited K+ flux through the diazoxide-opened mitochondrial K(ATP). The profile of activity of diazoxide (and perhaps K(ATP) openers in general) suggests that they protect ischemic hearts in a manner that is consistent with an interaction with mitochondrial K(ATP).",
keywords = "ATP-sensitive K channel, Heart, Mitochondria, Myocardial ischemia",
author = "Garlid, {Keith D.} and Petr Paucek and Vladimir Yarov-Yarovoy and Murray, {Holt N.} and Darbenzio, {Raymond B.} and D'Alonzo, {Albert J.} and Lodge, {Nicholas J.} and Smith, {Mark A.} and Grover, {Gary J.}",
year = "1997",
language = "English (US)",
volume = "81",
pages = "1072--1082",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels

T2 - Possible mechanism of cardioprotection

AU - Garlid, Keith D.

AU - Paucek, Petr

AU - Yarov-Yarovoy, Vladimir

AU - Murray, Holt N.

AU - Darbenzio, Raymond B.

AU - D'Alonzo, Albert J.

AU - Lodge, Nicholas J.

AU - Smith, Mark A.

AU - Grover, Gary J.

PY - 1997

Y1 - 1997

N2 - Previous studies showed a poor correlation between sarcolemmal K+ currents and cardioprotection for ATP-sensitive K+ channel (K(ATP)) openers. Diazoxide is a weak cardiac sarcolemmal K(ATP) opener, but it is a potent opener of mitochondrial K(ATP), making it a useful tool for determining the importance of this mitochondrial site. In reconstituted bovine heart K(ATP), diazoxide opened mitochondrial K(ATP) with a K( 1/4 ) of 0.8 μmol/L while being 1000-fold less potent at opening sarcolemmal K(ATP). To compare cardioprotective potency, diazoxide or cromakalim was given to isolated rat hearts subjected to 25 minutes of global ischemia and 30 minutes of reperfusion. Diazoxide and cromakalim increased the time to onset of contracture with a similar potency (EC25, 11.0 and 8.8 μmol/L, respectively) and improved postischemic functional recovery in a glibenclamide (glyburide)-reversible manner. In addition, sodium 5- hydroxydecanoic acid completely abolished the protective effect of diazoxide. Whole-myocyte studies showed that diazoxide was significantly less potent than cromakalim in increasing sarcolemmal K+ currents. Diazoxide shortened ischemic action potential duration significantly less than cromakalim at equicardioprotective concentrations. We also determined the effects of cromakalim and diazoxide on reconstituted rat mitochondrial cardiac K(ATP) activity. Cromakalim and diazoxide were both potent activators of K+ flux in this preparation (K( 1/4 ) values, 1.1±0.1 and 0.49±0.05 μmol/L, respectively). Both glibenclamide and sodium 5-hydroxydecanoic acid inhibited K+ flux through the diazoxide-opened mitochondrial K(ATP). The profile of activity of diazoxide (and perhaps K(ATP) openers in general) suggests that they protect ischemic hearts in a manner that is consistent with an interaction with mitochondrial K(ATP).

AB - Previous studies showed a poor correlation between sarcolemmal K+ currents and cardioprotection for ATP-sensitive K+ channel (K(ATP)) openers. Diazoxide is a weak cardiac sarcolemmal K(ATP) opener, but it is a potent opener of mitochondrial K(ATP), making it a useful tool for determining the importance of this mitochondrial site. In reconstituted bovine heart K(ATP), diazoxide opened mitochondrial K(ATP) with a K( 1/4 ) of 0.8 μmol/L while being 1000-fold less potent at opening sarcolemmal K(ATP). To compare cardioprotective potency, diazoxide or cromakalim was given to isolated rat hearts subjected to 25 minutes of global ischemia and 30 minutes of reperfusion. Diazoxide and cromakalim increased the time to onset of contracture with a similar potency (EC25, 11.0 and 8.8 μmol/L, respectively) and improved postischemic functional recovery in a glibenclamide (glyburide)-reversible manner. In addition, sodium 5- hydroxydecanoic acid completely abolished the protective effect of diazoxide. Whole-myocyte studies showed that diazoxide was significantly less potent than cromakalim in increasing sarcolemmal K+ currents. Diazoxide shortened ischemic action potential duration significantly less than cromakalim at equicardioprotective concentrations. We also determined the effects of cromakalim and diazoxide on reconstituted rat mitochondrial cardiac K(ATP) activity. Cromakalim and diazoxide were both potent activators of K+ flux in this preparation (K( 1/4 ) values, 1.1±0.1 and 0.49±0.05 μmol/L, respectively). Both glibenclamide and sodium 5-hydroxydecanoic acid inhibited K+ flux through the diazoxide-opened mitochondrial K(ATP). The profile of activity of diazoxide (and perhaps K(ATP) openers in general) suggests that they protect ischemic hearts in a manner that is consistent with an interaction with mitochondrial K(ATP).

KW - ATP-sensitive K channel

KW - Heart

KW - Mitochondria

KW - Myocardial ischemia

UR - http://www.scopus.com/inward/record.url?scp=0030780773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030780773&partnerID=8YFLogxK

M3 - Article

C2 - 9400389

AN - SCOPUS:0030780773

VL - 81

SP - 1072

EP - 1082

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -